Aug 28, 2025, 15:40
What if You Could Lock Disease Biology Into Place? – Amgen
Amgen shared a post on LinkedIn:
“What if you could lock disease biology into place?
Amgen scientists are pioneering a potential new way to treat disease with LOCKTAC molecular glues that lock proteins together to control biological activity.
AMG 193 is one example of a LOCKTAC glue that is designed to selectively target tumor cells that have lost a gene called MTAP, with the goal of sparing healthy tissue. This potential first-in-class molecule is now in clinical trials.
Amgen’s innovative approach is now featured in Science Magazine. Read more about how Amgen is innovating in this space.”
More posts featuring Amgen.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 28, 2025, 15:40
Aug 28, 2025, 15:28
Aug 28, 2025, 15:27
Aug 28, 2025, 15:15
Aug 28, 2025, 14:58
Aug 28, 2025, 14:33
Aug 28, 2025, 14:22